Diabetes medicines include insulin, tablets and other injectable treatments. They work in different ways, so a statement about one medicine cannot describe every diabetes treatment. Start an interaction search with the ingredients listed on the current prescription or packet.
More than one diabetes medicine may be part of an established treatment plan. When reading an interaction record, the useful question is what the named combination means in its clinical context, including any monitoring already arranged by the care team.
Unpack a combination product
Some product names represent more than one active ingredient. Write each ingredient separately before looking for relevant records. This makes it easier to recognise an ingredient that appears in both a combination tablet and another medicine on the list.
Keep the strength, formulation and brand alongside those ingredient names. For insulin, retain the complete name shown on the label. Describing a product simply as insulin or a diabetes tablet leaves out information needed to identify it accurately.
Separate glucose effects from other concerns
Some diabetes medicines can cause low blood glucose. A record may discuss a combination's effect on glucose control, while another record may concern a different side effect. Read the stated outcome rather than treating every interaction as the same issue.
Metformin is one example with its own interaction considerations, including some diuretics, anti-inflammatory painkillers and blood-pressure medicines. That example illustrates why a medicine-specific page is more informative than assuming that every treatment for diabetes shares one interaction list.
Prepare for a whole-list review
A useful pharmacy question is: Does this record describe the exact ingredients in my current treatment, and what part of the explanation needs discussion with my diabetes team? Include medicines bought without a prescription, vitamins and herbal products.
Bring recent prescription changes and the names of any temporary treatments into that review. Questions about changing treatment or monitoring belong with the treating team, which can connect an interaction entry with the existing diabetes care plan and individual circumstances.
English medicine records
Open a medicine record to check its identity, sources and available information. Products, formulations and licensed uses can differ by country.
- Metformin hydrochloride (Glucophage 1000 mg) — Medicine information in EnglishActive ingredient: Metformin hydrochloride
- Forxiga (Dapagliflozin): Uses, Safety and InteractionsActive ingredient: Dapagliflozin
- Empagliflozin 25 mg (Jardiance) — Medicine information in EnglishActive ingredient: Empagliflozin
- Januvia (Sitagliptin): Uses, Safety and InteractionsActive ingredient: Sitagliptin
- Diamicron MR 60 mg — Medicine information in EnglishActive ingredient: Gliclazide
- PioglitazoneActive ingredient: Pioglitazone
- GlipizideActive ingredient: Glipizide
- Teneligliptin: Uses, Safety and InteractionsActive ingredient: Teneligliptin
Documented interactions in English
Each link opens an existing, source-validated pair record. A missing record does not mean that there is no interaction.
- Cipro 500 mg and Diamicron MR 60 mg — Interaction information
- Apranax Fort 550 mg and Glipizide interaction
- Forxiga 10 mg and Glipizide interaction
- Glipizide and Glucophage 1000 mg interaction
- Glipizide and Januvia 100 mg interaction
- Glipizide and Jardiance 25 mg interaction
- Teneligliptin and Glucophage 1000 mg: Interaction Information
- Teneligliptin and Diamicron MR 60 mg: Interaction Information
- Racecadotril and Januvia 100 mg: Interaction Information
- Racecadotril and Teneligliptin: Interaction Information
Sources and scope
Sources checked: . Linked records carry their own sources and scope. Source checking is separate from review by a qualified clinician.